Tag: Daewoong Pharmaceutical

Zydus and Daewoong Pharmaceutical to co-develop and commercialise Leuprolide Acetate, announce exclusive licensing agreement

Published on Authored by The Free Press Journal

Zydus Worldwide DMCC and South Korea-based Daewoong Pharmaceutical on Monday (December 11, 2023) announced that they have entered an exclusive licensing agreement to co-develop and commercialise Leuprolide Acetate for Depot Suspension in six dosage strengths for the US market. The announcement was made through an exchange filing. As per the agreement, Zydus will assume full […]

About Tag: Daewoong Pharmaceutical

Warning: Unknown: write failed: No space left on device (28) in Unknown on line 0

Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/var/lib/php/sessions) in Unknown on line 0